Tyagi M, Fteropoulli T, Hurt CS, Hirani SP, Rixon L, Davies A, Picaut N, Kennedy F, Deanfield J, Cullen S, Newman SP. Cognitive dysfunction in adult CHD with different structural complexity. Cardiol Young. 2017;27:851–9.
Article
PubMed
Google Scholar
Arbab-Zadeh A, Fuster V. The risk continuum of atherosclerosis and its implications for defining CHD by coronary angiography. J Am Coll Cardiol. 2016;68:2467–78.
Article
PubMed
Google Scholar
Wong ND. Epidemiological studies of CHD and the evolution of preventive cardiology. Nat Rev Cardiol. 2014;11:276–89.
Article
PubMed
Google Scholar
Takada S, Kurita Y, Imanishi T, Otsuka A, Shinbo H, Furuse H, Nakanishi T, Suzuki A, Takase H, Ozono S. Arteriosclerosis related factors had no clinical significant correlation with resistive index in symptomatic benign prostatic hyperplasia. Urology. 2011;77:433–7.
Article
PubMed
Google Scholar
Ramalli EL Jr, Braga LH, Evora PM, Albuquerque AA, Celotto AC, Mota AL, Evora PR. Absence of arteriosclerosis in intramyocardial coronary arteries: a mystery to be solved? Rev Bras Cir Cardiovasc. 2011;26:440–6.
Article
PubMed
Google Scholar
Ma L, Zhang J, Liu Y. Roles and mechanisms of obstructive sleep Apnea-Hypopnea syndrome and chronic intermittent hypoxia in atherosclerosis: evidence and prospective. Oxidative Med Cell Longev. 2016;2016:8215082.
Google Scholar
Ohnuki T, Takahashi W, Ohnuki Y, Kawada S, Takizawa S. Significance of the presence of metabolic syndrome in patients with asymptomatic arteriosclerosis affecting the aorta and the cerebral, extra-cranial carotid and coronary arteries. Intern Med. 2013;52:523–7.
Article
PubMed
Google Scholar
Japan Arteriosclerosis Longitudinal Study G. Japan arteriosclerosis longitudinal study-existing cohorts combine (JALS-ECC): rationale, design, and population characteristics. Circ J. 2008;72:1563–8.
Article
Google Scholar
Fishbein MC, Fishbein GA. Arteriosclerosis: facts and fancy. Cardiovasc Pathol. 2015;24:335–42.
Article
PubMed
Google Scholar
Liu Y, Qi LT, Ma W, Yang Y, Meng L, Zhang BW, Huo Y. Relationship between radial augmentation index and other indices for evaluating arteriosclerosis. Beijing Da Xue Xue Bao. 2013;45:916–22.
CAS
PubMed
Google Scholar
Ren S, Qian S, Wang W, Liu J, Liu P. Prospective study of sarpogrelate hydrochloride on patients with arteriosclerosis obliterans. Ann Thorac Cardiovasc Surg. 2013;19:30–4.
Article
PubMed
Google Scholar
Bonner G, Gysan DB, Sauer G. Prevention of arteriosclerosis. Importance of the treatment of arterial hypertension. Z Kardiol. 2005;94(Suppl 3):III/56–65.
Google Scholar
Shimizu R, Torii H, Yasuda D, Hiraoka Y, Furukawa Y, Yoshimoto A, Iwakura T, Matsuoka N, Tomii K, Kohara N, et al. Comparison of serum lipid management between elderly and non-elderly patients with and without coronary heart disease (CHD). Prev Med Rep. 2016;4:192–8.
Article
PubMed
PubMed Central
Google Scholar
Ahola TL, Kantola IM, Puukka P, Kattainen A, Klaukka T, Reunanen A, Jula AM. Positive change in the utilization of antihypertensive and lipid-lowering drugs among adult CHD patients in Finland: results from a large national database between 2000 and 2006. Eur J Cardiovasc Prev Rehabil. 2010;17:477–85.
Article
PubMed
Google Scholar
Koro CE, L'Italien GJ, Fedder DO. Major CHD risk factors predominate among African-American women who are eligible for lipid-lowering drug therapy under the new ATP III guidelines. Eur J Cardiovasc Prev Rehabil. 2004;11:376–81.
Article
PubMed
Google Scholar
Eisenmann JC, Wrede J, Heelan KA. Associations between adiposity, family history of CHD and blood pressure in 3-8 year-old children. J Hum Hypertens. 2005;19:675–81.
Article
CAS
PubMed
Google Scholar
Brandon LJ, Mullis RM, Jonnalagadda SS, Hughes MH. Relationships and CHD risks of BMI, lipoproteins, lipids, and blood pressure in African-American men and women. Prev Med. 2005;40:349–54.
Article
PubMed
Google Scholar
Asia Pacific Cohort Studies C. Impact of cigarette smoking on the relationship between body mass index and coronary heart disease: a pooled analysis of 3264 stroke and 2706 CHD events in 378579 individuals in the Asia Pacific region. BMC Public Health. 2009;9:294.
Article
Google Scholar
Lightwood JM, Coxson PG, Bibbins-Domingo K, Williams LW, Goldman L. Coronary heart disease attributable to passive smoking: CHD policy model. Am J Prev Med. 2009;36:13–20.
Article
PubMed
PubMed Central
Google Scholar
Frothingham SM, Smith PO, Payne TJ, Meadows SE. Clinical inquiries: how much does smoking cessation cut CHD risk? J Fam Pract. 2008;57:675–6.
PubMed
Google Scholar
Fowler G. Passive smoking was associated with an increased risk of CHD. Evid Based Cardiovasc Med. 1997;1:92.
Article
CAS
PubMed
Google Scholar
Wienke A, Herskind AM, Christensen K, Skytthe A, Yashin AI. The heritability of CHD mortality in danish twins after controlling for smoking and BMI. Twin Res Hum Genet. 2005;8:53–9.
Article
PubMed
Google Scholar
Diverse Populations C. Smoking, body weight, and CHD mortality in diverse populations. Prev Med. 2004;38:834–40.
Article
Google Scholar
Kang MY, Hong YC. Inter-correlation between working hours, sleep duration, obesity, and 10-year risk for CHD. Am J Ind Med. 2016;59:338–9.
Article
PubMed
Google Scholar
Lin GM, Li YH, Lai CP, Lin CL, Wang JH. The obesity-mortality paradox in elderly patients with angiographic coronary artery disease: a report from the ET-CHD registry. Acta Cardiol. 2015;70:479–86.
Article
PubMed
Google Scholar
Kwagyan J, Retta TM, Ketete M, Bettencourt CN, Maqbool AR, Xu S, Randall OS. Obesity and cardiovascular diseases in a high-risk population: evidence-based approach to CHD risk reduction. Ethn Dis. 2015;25:208–13.
PubMed
PubMed Central
Google Scholar
Logue J. Obesity is an independent risk factor for death from CHD. Practitioner. 2011;255:5.
PubMed
Google Scholar
Ghosh A, Bose K, Das Chaudhuri AB. Association of food patterns, central obesity measures and metabolic risk factors for coronary heart disease (CHD) in middle aged Bengalee Hindu men, Calcutta, India. Asia Pac J Clin Nutr. 2003;12:166–71.
PubMed
Google Scholar
Brotons C, Soler-Soler J. Obesity, Cinderella of CHD risk factors. Eur Heart J. 2000;21:793–5.
Article
CAS
PubMed
Google Scholar
Gao N, Yuan Z, Tang X, Zhou X, Zhao M, Liu L, Ji J, Xue F, Ning G, Zhao J, et al. Prevalence of CHD-related metabolic comorbidity of diabetes mellitus in northern Chinese adults: the REACTION study. J Diabetes Complicat. 2016;30:199–205.
Article
CAS
PubMed
Google Scholar
Lockyer M. Women with diabetes at greater risk of CHD than men. Practitioner. 2014;258:7.
PubMed
Google Scholar
Soedamah-Muthu SS, Masset G, Verberne L, Geleijnse JM, Brunner EJ. Consumption of dairy products and associations with incident diabetes, CHD and mortality in the Whitehall II study. Br J Nutr. 2013;109:718–26.
Article
CAS
PubMed
Google Scholar
Southerland JH, Moss K, Taylor GW, Beck JD, Pankow J, Gangula PR, Offenbacher S. Periodontitis and diabetes associations with measures of atherosclerosis and CHD. Atherosclerosis. 2012;222:196–201.
Article
CAS
PubMed
Google Scholar
Kucharska-Newton A, Griswold M, Yao ZH, Foraker R, Rose K, Rosamond W, Wagenknecht L, Koton S, Pompeii L, Windham BG. Cardiovascular disease and patterns of change in functional status over 15 years: findings from the atherosclerosis risk in communities (ARIC) study. J Am Heart Assoc. 2017;6:e004144. https://doi.org/10.1161/JAHA.116.004144.
Weber C, Shantsila E, Hristov M, Caligiuri G, Guzik T, Heine GH, Hoefer IE, Monaco C, Peter K, Rainger E, et al. Role and analysis of monocyte subsets in cardiovascular disease. Joint consensus document of the European Society of Cardiology (ESC) working groups “Atherosclerosis & Vascular Biology” and “thrombosis”. Thromb Haemost. 2016;116:626–37.
Article
PubMed
Google Scholar
Yazouli LE, Criscuolo A, Hejaji H, Bouaaza M, Elmdaghri N, Alami AA, Amraoui A, Dakka N, Radouani F. Molecular characterization of Chlamydia pneumoniae associated to atherosclerosis. Pathog Dis. 2017;75. https://doi.org/10.1093/femspd/ftx039.
Patil K, Campbell LA, Rosenfeld ME, Paik J, Brabb T, O'Brien KD, Maggio-Price L, Hsu CC. Effects of Murine Norovirus on Chlamydia pneumoniae-accelerated atherosclerosis in ApoE(−/−) mice. Comp Med. 2016;66:188–96.
CAS
PubMed
PubMed Central
Google Scholar
Filardo S, Di Pietro M, Farcomeni A, Schiavoni G, Sessa R. Chlamydia pneumoniae-mediated inflammation in atherosclerosis: a meta-analysis. Mediat Inflamm. 2015;2015:378658.
Article
CAS
Google Scholar
Zafiratos MT, Manam S, Henderson KK, Ramsey KH, Murthy AK. CD8+ T cells mediate Chlamydia pneumoniae-induced atherosclerosis in mice. Pathog Dis. 2015;73. https://doi.org/10.1093/femspd/ftv052.
Sorrentino R, Yilmaz A, Schubert K, Crother TR, Pinto A, Shimada K, Arditi M, Chen S. A single infection with Chlamydia pneumoniae is sufficient to exacerbate atherosclerosis in ApoE deficient mice. Cell Immunol. 2015;294:25–32.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kreutmayer S, Csordas A, Kern J, Maass V, Almanzar G, Offterdinger M, Ollinger R, Maass M, Wick G. Chlamydia pneumoniae infection acts as an endothelial stressor with the potential to initiate the earliest heat shock protein 60-dependent inflammatory stage of atherosclerosis. Cell Stress Chaperones. 2013;18:259–68.
Article
CAS
PubMed
Google Scholar
Zhao X, Bu DX, Hayfron K, Pinkerton KE, Bevins CL, Lichtman A, Wiedeman J. A combination of secondhand cigarette smoke and Chlamydia pneumoniae accelerates atherosclerosis. Atherosclerosis. 2012;222:59–66.
Article
CAS
PubMed
Google Scholar
Wang Z, Cai J, Zhang M, Wang X, Chi H, Feng H, Yang X. Positive expression of human cytomegalovirus Phosphoprotein 65 in atherosclerosis. Biomed Res Int. 2016;2016:4067685.
PubMed
PubMed Central
Google Scholar
Zhang J, Liu YY, Sun HL, Li S, Xiong HR, Yang ZQ, Xiang GD, Jiang XJ. High human cytomegalovirus IgG level is associated with increased incidence of diabetic atherosclerosis in type 2 diabetes mellitus patients. Med Sci Monit. 2015;21:4102–10.
Article
PubMed
PubMed Central
Google Scholar
Heybar H, Alavi SM, Farashahi Nejad M, Latifi M. Cytomegalovirus infection and atherosclerosis in candidate of coronary artery bypass graft. Jundishapur J Microbiol. 2015;8:e15476.
Article
PubMed
PubMed Central
Google Scholar
Jeong SJ, Ku NS, Han SH, Choi JY, Kim CO, Song YG, Kim JM. Anti-cytomegalovirus antibody levels are associated with carotid atherosclerosis and inflammatory cytokine production in elderly Koreans. Clin Chim Acta. 2015;445:65–9.
Article
CAS
PubMed
Google Scholar
Xu Y, Wang Q, Liu Y, Cui R, Lu K, Zhao Y. Association between helicobacter pylori infection and carotid atherosclerosis in patients with vascular dementia. J Neurol Sci. 2016;362:73–7.
Article
CAS
PubMed
Google Scholar
Blum A. Helicobacter pylori and atherosclerosis. Isr Med Assoc J. 2015;17:396.
CAS
PubMed
Google Scholar
Karbasi-Afshar R, Khedmat H, Izadi M. Helicobacter pylori infection and atherosclerosis: a systematic review. Acta Med Iran. 2015;53:78–88.
PubMed
Google Scholar
He C, Yang Z, Lu NH. Helicobacter pylori-an infectious risk factor for atherosclerosis? J Atheroscler Thromb. 2014;21:1229–42.
Article
PubMed
Google Scholar
Kang SG, Chung WC, Song SW, Joo KR, Lee H, Kang D, Lee JS, Lee KM. Risk of atherosclerosis and helicobacter pylori infection according to CD14 Promotor polymorphism in healthy Korean population. Gastroenterol Res Pract. 2013;2013:570597.
Article
PubMed
PubMed Central
Google Scholar
Fabricant CG, Fabricant J, Minick CR, Litrenta MM. Herpesvirus-induced atherosclerosis in chickens. Fed Proc. 1983;42:2476–9.
CAS
PubMed
Google Scholar
Sacre K, Hunt PW, Hsue PY, Maidji E, Martin JN, Deeks SG, Autran B, McCune JM. A role for cytomegalovirus-specific CD4+CX3CR1+ T cells and cytomegalovirus-induced T-cell immunopathology in HIV-associated atherosclerosis. AIDS. 2012;26:805–14.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lunardi C, Dolcino M, Peterlana D, Bason C, Navone R, Tamassia N, Tinazzi E, Beri R, Corrocher R, Puccetti A. Endothelial cells’ activation and apoptosis induced by a subset of antibodies against human cytomegalovirus: relevance to the pathogenesis of atherosclerosis. PLoS One. 2007;2:e473.
Article
PubMed
PubMed Central
CAS
Google Scholar
Grahame-Clarke C. Human cytomegalovirus, endothelial function and atherosclerosis. Herpesviridae. 2005;12:42–5.
Google Scholar
Olofsson PS, Jatta K, Wagsater D, Gredmark S, Hedin U, Paulsson-Berne G, Soderberg-Naucler C, Hansson GK, Sirsjo A. The antiviral cytomegalovirus inducible gene 5/viperin is expressed in atherosclerosis and regulated by proinflammatory agents. Arterioscler Thromb Vasc Biol. 2005;25:e113–6.
Article
CAS
PubMed
Google Scholar
Bason C, Corrocher R, Lunardi C, Puccetti P, Olivieri O, Girelli D, Navone R, Beri R, Millo E, Margonato A, et al. Interaction of antibodies against cytomegalovirus with heat-shock protein 60 in pathogenesis of atherosclerosis. Lancet. 2003;362:1971–7.
Article
CAS
PubMed
Google Scholar
Chen R, Xiong S, Yang Y, Fu W, Wang Y, Ge J. The relationship between human cytomegalovirus infection and atherosclerosis development. Mol Cell Biochem. 2003;249:91–6.
Article
CAS
PubMed
Google Scholar
Melnick JL, Adam E, DeBakey ME. Cytomegalovirus and atherosclerosis. Arch Immunol Ther Exp. 1996;44:297–302.
CAS
Google Scholar
Melnick JL, Petrie BL, Dreesman GR, Burek J, McCollum CH, DeBakey ME. Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet. 1983;2:644–7.
Article
CAS
PubMed
Google Scholar
Horvath R, Cerny J, Benedik J Jr, Hokl J, Jelinkova I, Benedik J. The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis. J Clin Virol. 2000;16:17–24.
Article
CAS
PubMed
Google Scholar
Adam E, Melnick JL, Probtsfield JL, Petrie BL, Burek J, Bailey KR, McCollum CH, DeBakey ME. High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet. 1987;2:291–3.
Article
CAS
PubMed
Google Scholar
Eryol NK, Kilic H, Gul A, Ozdogru I, Inanc T, Dogan A, Topsakal R, Basar E. Are the high levels of cytomegalovirus antibodies a determinant in the development of coronary artery disease? Int Heart J. 2005;46:205–9.
Article
CAS
PubMed
Google Scholar
Simanek AM, Dowd JB, Pawelec G, Melzer D, Dutta A, Aiello AE. Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States. PLoS One. 2011;6:e16103.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gkrania-Klotsas E, Langenberg C, Sharp SJ, Luben R, Khaw KT, Wareham NJ. Higher immunoglobulin G antibody levels against cytomegalovirus are associated with incident ischemic heart disease in the population-based EPIC-Norfolk cohort. J Infect Dis. 2012;206:1897–903.
Article
CAS
PubMed
Google Scholar
Sorlie PD, Nieto FJ, Adam E, Folsom AR, Shahar E, Massing M. A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the atherosclerosis risk in communities (ARIC) study. Arch Intern Med. 2000;160:2027–32.
Article
CAS
PubMed
Google Scholar
Sorlie PD, Adam E, Melnick SL, Folsom A, Skelton T, Chambless LE, Barnes R, Melnick JL. Cytomegalovirus/herpesvirus and carotid atherosclerosis: the ARIC study. J Med Virol. 1994;42:33–7.
Article
CAS
PubMed
Google Scholar
Xenaki E, Hassoulas J, Apostolakis S, Sourvinos G, Spandidos DA. Detection of cytomegalovirus in atherosclerotic plaques and nonatherosclerotic arteries. Angiology. 2009;60:504–8.
Article
CAS
PubMed
Google Scholar
Reinhardt B, Vaida B, Voisard R, Keller L, Breul J, Metzger H, Herter T, Baur R, Luske A, Mertens T. Human cytomegalovirus infection in human renal arteries in vitro. J Virol Methods. 2003;109:1–9.
Article
CAS
PubMed
Google Scholar
Streblow DN, Kreklywich CN, Andoh T, Moses AV, Dumortier J, Smith PP, Defilippis V, Fruh K, Nelson JA, Orloff SL. The role of angiogenic and wound repair factors during CMV-accelerated transplant vascular sclerosis in rat cardiac transplants. Am J Transplant. 2008;8:277–87.
Article
CAS
PubMed
Google Scholar
De La Melena VT, Kreklywich CN, Streblow DN, Yin Q, Cook JW, Soderberg-Naucler C, Bruggeman CA, Nelson JA, Orloff SL. Kinetics and development of CMV-accelerated transplant vascular sclerosis in rat cardiac allografts is linked to early increase in chemokine expression and presence of virus. Transplant Proc. 2001;33:1822–3.
Article
CAS
PubMed
Google Scholar
Sambiase NV, Higuchi ML, Nuovo G, Gutierrez PS, Fiorelli AI, Uip DE, Ramires JA. CMV and transplant-related coronary atherosclerosis: an immunohistochemical, in situ hybridization, and polymerase chain reaction in situ study. Mod Pathol. 2000;13:173–9.
Article
CAS
PubMed
Google Scholar
Pouria S, State OI, Wong W, Hendry BM. CMV infection is associated with transplant renal artery stenosis. QJM. 1998;91:185–9.
Article
CAS
PubMed
Google Scholar
Fabricant CG, Fabricant J, Litrenta MM, Minick CR. Virus-induced atherosclerosis. J Exp Med. 1978;148:335–40.
Article
CAS
PubMed
Google Scholar
Lemstrom KB, Bruning JH, Bruggeman CA, Lautenschlager IT, Hayry PJ. Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts. J Clin Invest. 1993;92:549–58.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lemstrom KB, Bruning JH, Bruggeman CA, Koskinen PK, Aho PT, Yilmaz S, Lautenschlager IT, Hayry PJ. Cytomegalovirus infection-enhanced allograft arteriosclerosis is prevented by DHPG prophylaxis in the rat. Circulation. 1994;90:1969–78.
Article
CAS
PubMed
Google Scholar
Lemstrom KB, Koskinen PK, Bruning JH, Bruggeman CA, Lautenschlager IT, Hayry PJ. Effect of ganciclovir prophylaxis on cytomegalovirus-enhanced allograft arteriosclerosis. Transpl Int. 1994;7(Suppl 1):S383–4.
Article
PubMed
Google Scholar
Kloppenburg G, de Graaf R, Herngreen S, Grauls G, Bruggeman C, Stassen F. Cytomegalovirus aggravates intimal hyperplasia in rats by stimulating smooth muscle cell proliferation. Microbes Infect. 2005;7:164–70.
Article
CAS
PubMed
Google Scholar
Alber DG, Powell KL, Vallance P, Goodwin DA, Grahame-Clarke C. Herpesvirus infection accelerates atherosclerosis in the apolipoprotein E-deficient mouse. Circulation. 2000;102:779–85.
Article
CAS
PubMed
Google Scholar
Adler SP, Hur JK, Wang JB, Vetrovec GW. Prior infection with cytomegalovirus is not a major risk factor for angiographically demonstrated coronary artery atherosclerosis. J Infect Dis. 1998;177:209–12.
Article
CAS
PubMed
Google Scholar
Ridker PM, Hennekens CH, Stampfer MJ, Wang F. Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke. Circulation. 1998;98:2796–9.
Article
CAS
PubMed
Google Scholar
Rothenbacher D, Hoffmeister A, Bode G, Wanner P, Koenig W, Brenner H. Cytomegalovirus infection and coronary heart disease: results of a german case-control study. J Infect Dis. 1999;179:690–2.
Article
CAS
PubMed
Google Scholar
Rahbar A, Soderberg-Naucler C. Human cytomegalovirus infection of endothelial cells triggers platelet adhesion and aggregation. J Virol. 2005;79:2211–20.
Article
CAS
PubMed
PubMed Central
Google Scholar
Taveira A, Ponroy N, Mueller NJ, Millard AL. Entry of human cytomegalovirus into porcine endothelial cells depends on both the cellular vascular origin and the viral strain. Xenotransplantation. 2014;21:324–40.
Article
PubMed
Google Scholar
Niyi-Odumosu FA, Bello OA, Biliaminu SA, Owoyele BV, Abu TO, Dominic OL. Resting serum concentration of high-sensitivity C-reactive protein (hs-CRP) in sportsmen and untrained male adults. Niger J Physiol Sci. 2017;31:177–81.
CAS
PubMed
Google Scholar
Mukherjee S, Barman S, Mandal NC, Bhattacharya S. Anti-bacterial activity of Achatina CRP and its mechanism of action. Indian J Exp Biol. 2014;52:692–704.
PubMed
Google Scholar
Varol E, Aksoy F, Icli A, Arslan A, Yuksel O, Ersoy IH, Varol S, Dogan A. Increased plasma neopterin and hs-CRP levels in patients with endemic fluorosis. Bull Environ Contam Toxicol. 2012;89:931–6.
Article
CAS
PubMed
Google Scholar
De Backer J, Mak R, De Bacquer D, Van Renterghem L, Verbraekel E, Kornitzer M, De Backer G. Parameters of inflammation and infection in a community based case-control study of coronary heart disease. Atherosclerosis. 2002;160:457–63.
Article
CAS
PubMed
Google Scholar
Alavi SM, Adel SM, Rajabzadeh AR. An evidence against the effect of chronic cytomegalovirus infection in unstable angina pectoris. Acta Med Iran. 2011;49:78–80.
PubMed
Google Scholar
Ridker PM. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol. 2007;49:2129–38.
Article
CAS
PubMed
Google Scholar
Biasucci LM, Liuzzo G, Grillo RL, Caligiuri G, Rebuzzi AG, Buffon A, Summaria F, Ginnetti F, Fadda G, Maseri A. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation. 1999;99:855–60.
Article
CAS
PubMed
Google Scholar
van de Berg PJ, Heutinck KM, Raabe R, Minnee RC, Young SL, van Donselaar-van der Pant KA, Bemelman FJ, van Lier RA, ten Berge IJ. Human cytomegalovirus induces systemic immune activation characterized by a type 1 cytokine signature. J Infect Dis. 2010;202:690–9.
Article
CAS
PubMed
Google Scholar
Popovic M, Smiljanic K, Dobutovic B, Syrovets T, Simmet T, Isenovic ER. Human cytomegalovirus infection and atherothrombosis. J Thromb Thrombolysis. 2012;33:160–72.
Article
CAS
PubMed
Google Scholar
Muller WA. New mechanisms and pathways for monocyte recruitment. J Exp Med. 2001;194:F47–51.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bakst RL, Xiong H, Chen CH, Deborde S, Lyubchik A, Zhou Y, He S, McNamara WF, Lee SY, Olson OC, et al. Inflammatory monocytes promote perineural invasion via CCL2-mediated recruitment and cathepsin B expression. Cancer Res. 2017;72:6400.
Article
CAS
Google Scholar
Silva AR, Pacheco P, Vieira-de-Abreu A, Maya-Monteiro CM, D'Alegria B, Magalhaes KG, de Assis EF, Bandeira-Melo C, Castro-Faria-Neto HC, Bozza PT. Lipid bodies in oxidized LDL-induced foam cells are leukotriene-synthesizing organelles: a MCP-1/CCL2 regulated phenomenon. Biochim Biophys Acta. 2009;1791:1066–75.
Article
CAS
PubMed
Google Scholar
Izadi M, Fazel M, Saadat SH, Nasseri MH, Ghasemi M, Dabiri H, Aryan RS, Esfahani AA, Ahmadi A, Kazemi-Saleh D, et al. Cytomegalovirus localization in atherosclerotic plaques is associated with acute coronary syndromes: report of 105 patients. Methodist Debakey Cardiovasc J. 2012;8:42–6.
Article
PubMed
PubMed Central
Google Scholar
Speir E, Shibutani T, Yu ZX, Ferrans V, Epstein SE. Role of reactive oxygen intermediates in cytomegalovirus gene expression and in the response of human smooth muscle cells to viral infection. Circ Res. 1996;79:1143–52.
Article
CAS
PubMed
Google Scholar
Schroer J, Shenk T. Inhibition of cyclooxygenase activity blocks cell-to-cell spread of human cytomegalovirus. Proc Natl Acad Sci U S A. 2008;105:19468–73.
Article
PubMed
PubMed Central
CAS
Google Scholar
Zhu H, Cong JP, Yu D, Bresnahan WA, Shenk TE. Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication. Proc Natl Acad Sci U S A. 2002;99:3932–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004;109:III27–32.
Article
PubMed
Google Scholar
Ryckman BJ, Rainish BL, Chase MC, Borton JA, Nelson JA, Jarvis MA, Johnson DC. Characterization of the human cytomegalovirus gH/gL/UL128-131 complex that mediates entry into epithelial and endothelial cells. J Virol. 2008;82:60–70.
Article
CAS
PubMed
Google Scholar
Gharavi AE, Pierangeli SS, Harris EN. Viral origin of antiphospholipid antibodies: endothelial cell activation and thrombus enhancement by CMV peptide-induced APL antibodies. Immunobiology. 2003;207:37–42.
Article
CAS
PubMed
Google Scholar
Prochnau D, Straube E, Figulla HR, Rodel J. Supra-additive expression of interleukin-6, interleukin-8 and basic fibroblast growth factor in vascular smooth muscle cells following coinfection with Chlamydia pneumoniae and cytomegalovirus as a novel link between infection and atherosclerosis. Can J Infect Dis Med Microbiol. 2012;23:e26–30.
PubMed
PubMed Central
Google Scholar
Koskinen PK, Kallio EA, Bruggeman CA, Lemstrom KB. Cytomegalovirus infection enhances experimental obliterative bronchiolitis in rat tracheal allografts. Am J Respir Crit Care Med. 1997;155:2078–88.
Article
CAS
PubMed
Google Scholar
Grey F, Tirabassi R, Meyers H, Wu G, McWeeney S, Hook L, Nelson JA. A viral microRNA down-regulates multiple cell cycle genes through mRNA 5'UTRs. PLoS Pathog. 2010;6:e1000967.
Article
PubMed
PubMed Central
CAS
Google Scholar
Low H, Mukhamedova N, Cui HL, McSharry BP, Avdic S, Hoang A, Ditiatkovski M, Liu Y, Fu Y, Meikle PJ, et al. Cytomegalovirus restructures lipid rafts via a US28/CDC42-mediated pathway, enhancing cholesterol efflux from host cells. Cell Rep. 2016;16:186–200.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rott D, Zhu J, Zhou YF, Burnett MS, Zalles-Ganley A, Epstein SE. IL-6 is produced by splenocytes derived from CMV-infected mice in response to CMV antigens, and induces MCP-1 production by endothelial cells: a new mechanistic paradigm for infection-induced atherogenesis. Atherosclerosis. 2003;170:223–8.
Article
CAS
PubMed
Google Scholar
Lager S, Jansson N, Olsson AL, Wennergren M, Jansson T, Powell TL. Effect of IL-6 and TNF-alpha on fatty acid uptake in cultured human primary trophoblast cells. Placenta. 2011;32:121–7.
Article
CAS
PubMed
Google Scholar
Li L, Li Y, Dai Z, Liu M, Wang B, Liu S, Wang L, Chen L, Tan Y, Wu G. Lipid metabolism in vascular smooth muscle cells Infuenced by HCMV infection. Cell Physiol Biochem. 2016;39:1804–12.
Article
PubMed
CAS
Google Scholar
Dobesh PP, Swahn SM, Peterson EJ, Olsen KM. Statins in sepsis. J Pharm Pract. 2010;23:38–49.
Article
PubMed
Google Scholar
Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold KR, Grunfeld C. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res. 2004;45:1169–96.
Article
CAS
PubMed
Google Scholar
Sanchez V, Dong JJ. Alteration of lipid metabolism in cells infected with human cytomegalovirus. Virology. 2010;404:71–7.
Article
CAS
PubMed
Google Scholar
Guo N, Zhang N, Yan L, Cao X, Lv F, Wang J, Wang Y, Cong H. Down-regulation of single-stranded DNA-binding protein 1 expression induced by HCMV infection promotes lipid accumulation in cells. Braz J Med Biol Res. 2017;50:e6389.
CAS
PubMed
PubMed Central
Google Scholar
Zhou YF, Guetta E, Yu ZX, Finkel T, Epstein SE. Human cytomegalovirus increases modified low density lipoprotein uptake and scavenger receptor mRNA expression in vascular smooth muscle cells. J Clin Invest. 1996;98:2129–38.
Article
CAS
PubMed
PubMed Central
Google Scholar
Pasquereau S, Al Moussawi F, Karam W, Diab Assaf M, Kumar A, Herbein G. Cytomegalovirus, macrophages and breast cancer. Open Virol J. 2017;11:15–27.
Article
CAS
PubMed
PubMed Central
Google Scholar
Joseph GP, McDermott R, Baryshnikova MA, Cobbs CS, Ulasov IV. Cytomegalovirus as an oncomodulatory agent in the progression of glioma. Cancer Lett. 2017;384:79–85.
Article
CAS
PubMed
Google Scholar
Schlick K, Grundbichler M, Auberger J, Kern JM, Hell M, Hohla F, Hopfinger G, Greil R. Cytomegalovirus reactivation and its clinical impact in patients with solid tumors. Infect Agent Cancer. 2015;10:45.
Article
PubMed
PubMed Central
Google Scholar
Li Y, Guo Y, Chen Y, Wang Y, You Y, Yang Q, Weng X, Li Q, Zhu X, Zhou B, et al. Establishment of an interleukin-1beta-induced inflammation-activated endothelial cell-smooth muscle cell-mononuclear cell co-culture model and evaluation of the anti-inflammatory effects of tanshinone IIA on atherosclerosis. Mol Med Rep. 2015;12:1665–76.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tang-Feldman YJ, Lochhead SR, Lochhead GR, Yu C, George M, Villablanca AC, Pomeroy C. Murine cytomegalovirus (MCMV) infection upregulates P38 MAP kinase in aortas of Apo E KO mice: a molecular mechanism for MCMV-induced acceleration of atherosclerosis. J Cardiovasc Transl Res. 2013;6:54–64.
Article
PubMed
Google Scholar
Speir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, Epstein SE. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science. 1994;265:391–4.
Article
CAS
PubMed
Google Scholar
Castillo JP, Yurochko AD, Kowalik TF. Role of human cytomegalovirus immediate-early proteins in cell growth control. J Virol. 2000;74:8028–37.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tanaka K, Zou JP, Takeda K, Ferrans VJ, Sandford GR, Johnson TM, Finkel T, Epstein SE. Effects of human cytomegalovirus immediate-early proteins on p53-mediated apoptosis in coronary artery smooth muscle cells. Circulation. 1999;99:1656–9.
Article
CAS
PubMed
Google Scholar
Poole E, Bain M, Teague L, Takei Y, Laskey R, Sinclair J. The cellular protein MCM3AP is required for inhibition of cellular DNA synthesis by the IE86 protein of human cytomegalovirus. PLoS One. 2012;7:e45686.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhou YF, Yu ZX, Wanishsawad C, Shou M, Epstein SE. The immediate early gene products of human cytomegalovirus increase vascular smooth muscle cell migration, proliferation, and expression of PDGF beta-receptor. Biochem Biophys Res Commun. 1999;256:608–13.
Article
CAS
PubMed
Google Scholar
Reinhardt B, Mertens T, Mayr-Beyrle U, Frank H, Luske A, Schierling K, Waltenberger J. HCMV infection of human vascular smooth muscle cells leads to enhanced expression of functionally intact PDGF beta-receptor. Cardiovasc Res. 2005;67:151–60.
Article
CAS
PubMed
Google Scholar
Kervinen H, Palosuo T, Manninen V, Tenkanen L, Vaarala O, Manttari M. Joint effects of C-reactive protein and other risk factors on acute coronary events. Am Heart J. 2001;141:580–5.
Article
CAS
PubMed
Google Scholar
Corrado E, Novo S. Role of inflammation and infection in vascular disease. Acta Chir Belg. 2005;105:567–79.
Article
CAS
PubMed
Google Scholar
Sadowitz B, Maier KG, Gahtan V. Basic science review: Statin therapy--part I: the pleiotropic effects of statins in cardiovascular disease. Vasc Endovasc Surg. 2010;44:241–51.
Article
Google Scholar
Hsu JL, van den Boomen DJ, Tomasec P, Weekes MP, Antrobus R, Stanton RJ, Ruckova E, Sugrue D, Wilkie GS, Davison AJ, et al. Plasma membrane profiling defines an expanded class of cell surface proteins selectively targeted for degradation by HCMV US2 in cooperation with UL141. PLoS Pathog. 2015;11:e1004811.
Article
PubMed
PubMed Central
CAS
Google Scholar
Froberg MK, Dannen D, Adams A, Parker-Thornburg J, Kolattukudy P. Murine cytomegalovirus infection markedly reduces serum MCP-1 levels in MCP-1 transgenic mice. Ann Clin Lab Sci. 2006;36:179–84.
CAS
PubMed
Google Scholar
Chen K, Chen J, Liu Y, Xie J, Li D, Sawamura T, Hermonat PL, Mehta JL. Adhesion molecule expression in fibroblasts: alteration in fibroblast biology after transfection with LOX-1 plasmids. Hypertension. 2005;46:622–7.
Article
CAS
PubMed
Google Scholar
Bolovan-Fritts CA, Spector SA. Endothelial damage from cytomegalovirus-specific host immune response can be prevented by targeted disruption of fractalkine-CX3CR1 interaction. Blood. 2008;111:175–82.
Article
CAS
PubMed
PubMed Central
Google Scholar
Waldman WJ, Knight DA, Huang EH, Sedmak DD. Bidirectional transmission of infectious cytomegalovirus between monocytes and vascular endothelial cells: an in vitro model. J Infect Dis. 1995;171:263–72.
Article
CAS
PubMed
Google Scholar
Gerna G. Endothelial cells and CMV dissemination. Future Microbiol. 2012;7:441–4.
Article
CAS
PubMed
Google Scholar
Guetta E, Guetta V, Shibutani T, Epstein SE. Monocytes harboring cytomegalovirus: interactions with endothelial cells, smooth muscle cells, and oxidized low-density lipoprotein. Possible mechanisms for activating virus delivered by monocytes to sites of vascular injury. Circ Res. 1997;81:8–16.
Article
CAS
PubMed
Google Scholar